Acumen Pharmaceuticals, Inc.
Balance Sheet
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $68.0M | $46.9M | $66.9M | $94.9M | $77.2M | $78.0M | $130.1M | $157.5M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $266.9M | $255.8M | $246.6M | $218.6M | $149.5M | $144.0M | $180.3M | $202.6M |
| Property, Plant & Equipment | $105.0K | $117.0K | $122.0K | $123.0K | $136.0K | $151.0K | $165.0K | $142.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $288.9M | $301.0M | $310.1M | $286.4M | $177.4M | $187.9M | $196.6M | $203.3M |
| Liabilities | ||||||||
| Accounts Payable | $4.2M | $3.1M | $1.4M | $1.4M | $2.0M | $762.0K | $1.6M | $2.1M |
| Total Current Liabilities | $15.4M | $8.5M | $13.0M | $6.1M | $8.5M | $8.8M | $7.8M | $6.6M |
| Long-Term Debt | $29.4M | $30.2M | $29.9M | — | — | — | $0 | — |
| Total Liabilities | $45.0M | $38.9M | $43.2M | $6.1M | $8.5M | $8.8M | $7.8M | $6.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-258.2M | $-237.7M | $-222.8M | $-206.3M | $-193.3M | $-181.7M | $-170.4M | $-157.6M |
| Total Stockholders' Equity | $243.9M | $262.0M | $267.0M | $280.3M | $168.9M | $179.1M | $188.8M | $196.7M |